Moreover, tumours resistant to treatment with SSAs showed reduced CD8+ TILs compared with responsive tumours, while the number of CD8+ TILs did not differ in tumours with different SSTR2 expression or between sparsely and densely granulated tumours. This evidence concerns the gene SSTR2 and neoplasm.